Table 1. Stems of SCEs Used at Least 10 Times in the Last 20 Years.
ranking of stems in SCEs | stem | definition | example |
---|---|---|---|
#1a | -ine | alkaloids and organic bases | atropine (according to WHO, ∼17.5% of INNs have used this stem in lists p1-p119)9 |
#2b | -tinib | tyrosine kinase inhibitors | imatinib |
#3b | -stat–/–stat | enzyme inhibitors | atorvastatin, cobicistat |
#3b | vir–/–vir–/–vir | antivirals (undefined group) | maraviroc, remdesivir |
#5b | gli–/–gli- | antihyperglycaemics | glibenclamide, dapagliflozin |
#5a | -one | ketones | naloxone (according to WHO, ∼7.5% of INNs have used this stem in lists p1-p105)9 |
#7b | -imod | immunomodulators, both stimulant/suppressive and stimulant | fingolimod |
#8 | -sertib | serine/threonine kinase inhibitors | no drug is yet on the market |
#9c | fos–/–fos- | phosphorus derivatives; various pharmacological categories belonging to “fos”, other than insecticides, anthelminthics, pesticides, etc. | foscarnet, sofosbuvir |
#10 | -lisib | phosphatidylinositol 3-kinase inhibitors, antineoplastics | idelalisib |
#11b | -ast | antiallergic or anti-inflammatory, not acting as antihistaminics | zafirlukast |
#11b | -tant | neurokinin (tachykinin) receptor antagonists | aprepitant |
#13 | -anib | angiogenesis inhibitors | nintedanib |
#13 | -bulin | antineoplastics; mitotic inhibitors, tubulin binders | eribulin |
#13 | -ciclib | cyclin dependent kinase inhibitors | palbociclib |
#16b | -abine | arabinofuranosyl derivatives; nucleosides antiviral or antineoplastic agents, cytarabine or azacitidine derivatives | capecitabine |
#17 | -entan | endothelin receptor antagonists | bosentan |
#17 | -oxacin | antibacterials, nalidixic acid derivatives | levofloxacin |
#19 | -conazole | systemic antifungal agents, miconazole derivatives | ketoconazole |
#19b | prost–/–prost–/–prost | prostaglandins | prostalene (veterinary use), misoprostol, latanoprost |
#21 | -caftor | cystic fibrosis transmembrane regulator (CFTR) protein modulators, correctors, and amplifiers | ivacaftor |
#21 | -nicline | nicotinic acetylcholine receptor partial agonists/agonists | varenicline |
#23 | -tecan | antineoplastics, topoisomerase I inhibitors | irinotecan |
#23 | -adol–/–adol | analgesics | tramadol |
#23 | -ciguat | guanylate cyclase activators and stimulators | riociguat |
#23 | -denoson | adenosine A receptor agonists | regadenoson |
#27 | -parib | poly-ADP-Ribose polymerase inhibitors | olaparib |
#27 | -terol | bronchodilators, phenethylamine derivatives | formoterol |
#27 | -vaptan | vasopressin receptor antagonists | tolvaptan |
A number of other stems include this one (e.g., -terone for androgens).
These stems possess substems that categorize in more detail. For example, -brutinib, -citinib, -ertinib, and -metinib group together tyrosine kinase inhibitors (-tinib) with the same target (Bruton kinase, Janus Kinase, EGFR, MAPK, respectively).
The stem -fos is, instead, used for insecticides, anthelmintics, pesticides, etc., phosphorus derivatives.